Andere Sprachen Calidi Biotherapeutics, Inc.

Aktien

A3DGDT

US3207031010

CLDI

Verzögert Nyse Andere Börsenplätze 20:34:13 26.06.2024			% 5 Tage	% 1. Jan.
0.1857 ^USD	-1.22%		-4.77%	-87.70%

10.06.	Sektor-Update: Aktien des Gesundheitswesens legen am späten Nachmittag zu	MT
10.06.	Sektor Update: Gesundheitswesen	MT

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

Calidi Biotherapeutics to Host Exclusive Live Investor Webinar and Q&A Session on June 13	11.06.
Sector Update: Health Care Stocks Advance Late Afternoon	10.06.
Sector Update: Health Care	10.06.
Calidi Biotherapeutics Signs Virotherapy Deal With Siga Technologies -- Calidi Shares Surge Pre-Bell	10.06.
Calidi Biotherapeutics Collaborates with SIGA Technologies to Advance Calidi’s Revolutionary RTNova Virotherapy for Lung Cancer and Metastatic Solid Tumors	10.06.
Calidi Biotherapeutics Collaborates with Siga Technologies to Advance Calidi?S Revolutionary Rtnova Virotherapy for Lung Cancer and Metastatic Solid Tumors	10.06.
Calidi Biotherapeutics Presents CLD-101 Phase 1 Trial Update and Preclinical Data Highlighting RTNova and CLD-201 at 2024 ASCO Annual Meeting	03.06.
Calidi Biotherapeutics Presents Cld-101 Phase 1 Trial Update and Preclinical Data Highlighting Rtnova and Cld-201 At 2024 Asco Annual Meeting	03.06.
Calidi Biotherapeutics Announces Exercise of Warrants for $2.1 Million Gross Proceeds	31.05.
Calidi Biotherapeutics, Inc. Announces Resignation of David Lapre as Director	16.05.
Calidi Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	14.05.
Calidi Biotherapeutics Reports First Quarter 2024 Operating and Financial Results	14.05.
Calidi Biotherapeutics Announces Upcoming Presentations at the 2024 ASCO Annual Meeting	01.05.
Join Calidi Biotherapeutics Exclusive Live Investor Webinar and Q&A Session on April 24	24.04.
Join Calidi Biotherapeutics’ Exclusive Live Investor Webinar and Q&A Session on April 24	23.04.
Calidi Biotherapeutics, Inc. Announces Closing of $6.1 Million Public Offering	19.04.
Calidi Biotherapeutics Prices $6.1 Million Offering	16.04.
Calidi Biotherapeutics, Inc. Announces Pricing of $6.1 Million Public Offering	16.04.
Calidi Biotherapeutics Presents New Data on the Mechanisms of Action for Virotherapy-Loaded Stem Cells Used in the Company's Novel Immunotherapies at the AACR Annual Meeting 2024	10.04.
Calidi Biotherapeutics Presents New Data on the Mechanisms of Action for Virotherapy-Loaded Stem Cells Used in the Company’s Novel Immunotherapies at the AACR Annual Meeting 2024	09.04.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Calidi Biotherapeutics, Inc.

Aktien

A3DGDT

US3207031010

CLDI

Andere Sprachen

Filter